⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LGND News
Ligand Pharmaceuticals Inc.
Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance
globenewswire.com
LGND
Die frühere Anwendung von CARVYKTI®▼ (ciltacabtagene autoleucel) führte bei Patienten mit rezidiviertem oder refraktärem Multiplem Myelom nach 2,5 Jahren zu einer anhaltenden, behandlungsfreien Remission
globenewswire.com
JNJ
LGND
Earlier use of CARVYKTI®▼ (ciltacabtagene autoleucel) demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple myeloma
globenewswire.com
JNJ
LGND
United States Washing Machine Market Trends & Forecast Report 2025-2033 Featuring Whirlpool, Samsung, LG, IFB, Panasonic, Haier, Godrej, General Electric, and Electrolux
globenewswire.com
WHR
SSNLF
LGND
GE
ELUX-B
Exploring the Next Era of CGT and Unlocking Limitless Possibilities: The GenScript Biotech Global Forum London 2025 Wraps Up
prnewswire.com
LGND
JNJ
AZN
GSBC
Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance
globenewswire.com
LGND
Ligand to Participate in November Investor Conferences
globenewswire.com
LGND
Ligand to Host Investor Day on December 9, 2025
globenewswire.com
LGND
Ligand Partner SQ Innovation Receives FDA Approval for Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Patients
globenewswire.com
LGND